Skip to main content

Advertisement

Table 1 Demographic data of subjects recruited in this study

From: Increased interleukin-23 receptor+T cells in peripheral blood mononuclear cells of patients with systemic lupus erythematosus

Characteristics Active SLE Group Inactive SLE Group Psoriasis Group Control Group
Numbers 13 16 5 10
Sex, female:male 12:1 16:0 3:2 10:0
Age, years 15 to 50 17 to 50 39 to 61 24 to 28
(mean ± S.D.) (34.62 ± 11.46) (33 ± 11.16) (51 ± 9.88) (25.6 ± 1.58)
SLEDAI score ≥ 6 < 6 - -
(mean ± S.D.) (12.92 ± 7.83) (2.56 ± 2.03)   
Range of PASI score    11.2 to 27  
(mean ± S.D.) - - (18.02 ± 5.38) -
Treatment (mg/day)     
(mean ± S.D.)     
   Prednisolone 13.13 ± 10.06 9.38 ± 8.45 - -
   Cyclophosphamide - 25 - -
   Azathioprine 50 ± 30.62 47.5 ± 33.54 - -
   Mycophenolate mofetil 1,250 - - -
   Methotrexate - - 6.43